Makiko Yomota

Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial

Daichi Fujimoto, Makiko Yomota, Akimasa Sekine et al. · Lung Cancer · 2019 · 87 citations

Translational Medicine, Advanced Lung Disease, Medicine +5

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan

Ryo Morita, Kyoichi Okishio, Junichi Shimizu et al. · Lung Cancer · 2019 · 70 citations · Full text

Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Yasuhiro Kato, Yukio Hosomi, Kageaki Watanabe et al. · Journal of Thoracic Disease · 2019 · 54 citations · Full text

Management of Cardiac Tamponade During Nivolumab Of Lung Cancer with Intrapericardial Bleomycin: Case Report

Maiko Asai, Yasuhiro Kato, Shoko Kawai et al. · Immunotherapy · 2019 · 26 citations · Full text

Medicine, Pathology, Advanced Lung Adenocarcinoma +11

Histologic transformation of epidermal growth factor receptor–mutated lung cancer

Daichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto et al. · European Journal of Cancer · 2022 · 26 citations

Tumor Biology, Pathology, Medicine +3